1. Home
  2. PBMWW vs CSV Comparison

PBMWW vs CSV Comparison

Compare PBMWW & CSV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBMWW
  • CSV
  • Stock Information
  • Founded
  • PBMWW N/A
  • CSV 1991
  • Country
  • PBMWW Canada
  • CSV United States
  • Employees
  • PBMWW 10
  • CSV N/A
  • Industry
  • PBMWW
  • CSV Other Consumer Services
  • Sector
  • PBMWW
  • CSV Consumer Discretionary
  • Exchange
  • PBMWW Nasdaq
  • CSV Nasdaq
  • Market Cap
  • PBMWW N/A
  • CSV N/A
  • IPO Year
  • PBMWW N/A
  • CSV 1996
  • Fundamental
  • Price
  • PBMWW $0.01
  • CSV $38.15
  • Analyst Decision
  • PBMWW
  • CSV Strong Buy
  • Analyst Count
  • PBMWW 0
  • CSV 2
  • Target Price
  • PBMWW N/A
  • CSV $42.50
  • AVG Volume (30 Days)
  • PBMWW N/A
  • CSV 99.4K
  • Earning Date
  • PBMWW N/A
  • CSV 10-30-2024
  • Dividend Yield
  • PBMWW N/A
  • CSV 1.18%
  • EPS Growth
  • PBMWW N/A
  • CSV 15.90
  • EPS
  • PBMWW N/A
  • CSV 2.23
  • Revenue
  • PBMWW N/A
  • CSV $405,332,000.00
  • Revenue This Year
  • PBMWW N/A
  • CSV $0.29
  • Revenue Next Year
  • PBMWW N/A
  • CSV $10.19
  • P/E Ratio
  • PBMWW N/A
  • CSV $17.08
  • Revenue Growth
  • PBMWW N/A
  • CSV 7.34
  • 52 Week Low
  • PBMWW N/A
  • CSV $21.20
  • 52 Week High
  • PBMWW N/A
  • CSV $40.47
  • Technical
  • Relative Strength Index (RSI)
  • PBMWW N/A
  • CSV 65.38
  • Support Level
  • PBMWW N/A
  • CSV $32.31
  • Resistance Level
  • PBMWW N/A
  • CSV $40.47
  • Average True Range (ATR)
  • PBMWW 0.00
  • CSV 1.20
  • MACD
  • PBMWW 0.00
  • CSV 0.11
  • Stochastic Oscillator
  • PBMWW 0.00
  • CSV 71.57

About PBMWW Psyence Biomedical Ltd. Warrant

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: